Industry Leaders Join 23andMe Board of Directors
Dr. Valerie Montgomery Rice and Peter Taylor Join 23andMe’s Board as the Company Sets to Accelerate Personalized Healthcare Based on...
News
C4 Therapeutics Presents Pre-clinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the 16th Annual International Conference on Malignant Lymphoma
– CFT7455 Demonstrated High Binding Affinity to Cereblon and Target Selectivity in Non-Hodgkin’s Lymphoma Cell Models, Producing Rapid and Deep...
Aligos Therapeutics to Present Phase 1 Safety and Pharmacokinetic Data for STOPS™ Molecule Drug Candidate ALG-010133 and Several Nonclinical Chronic Hepatitis B Programs at the European Association for the Study of the Liver’s Digital International Liver Congress 2021
-First clinical data presented for ALG-010133, which is in development for S-antigen reduction in chronic hepatitis B (CHB) patients-Presentations include...
Alignment Healthcare Expands Its Health Plan Choices With Medicare Advantage Preferred Provider Organization (PPO) Plans in Markets Nationwide
ORANGE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Medicare Advantage company Alignment Healthcare (NASDAQ: ALHC) today announced the expansion of...
BioCardia Announces European Patent Office Decision to Grant Patent on Autologous Cell Therapy Patient Selection Diagnostic Assay
SAN CARLOS, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a company focused on cellular and cell-derived therapeutics for...
Kymera Therapeutics Presents New Preclinical Data for its IRAKIMiD Degrader KT-413 Demonstrating Strong Antitumor Activity as Both Monotherapy and in Combination in MYD88-mutant Lymphoma Models
Data presented at the 16th ICML Meeting demonstrate KT-413’s potent antitumor activity as a monotherapy compared to a clinically active...
ORYZON to Present New Clinical Data and Corporate Updates at International Conferences in June and July
NewYorkBIO and NYSE’s Emerging Biotech Company ShowcaseSpring European Virtual MidCap Event31st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID-2021)Epigenetic...
Recce Pharmaceuticals to Present at World Microbe Forum
SYDNEY, Australia, June 21, 2021 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE) (FSE:R9Q) (Company), the Company developing new classes of...
CymaBay Therapeutics Presents Positive PBC Data at the International Liver Congress™ 2021
New analyses adds to the growing body of evidence for seladelpar’s potential as a treatment for patients with PBCNEWARK, Calif.,...
Intercept to Present New NASH and PBC Data at the Digital International Liver Congress™ 2021
New analyses from the Phase 3 REGENERATE study highlight the relationship between early reductions of aminotransferases and fibrosis improvement in...
Immutep Completes a A$60 Million Placement to Expand its Clinical Development and Manufacturing Program into Late-Stage Settings
Sydney, AUSTRALIA, June 21, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or Company), is pleased to...
CytomX Therapeutics Announces Publication of First-in-Human Data for CX-2029 in Clinical Cancer Research
CX-2029 is the first CD71-targeting antibody-drug conjugate (ADC) administrated to patients, with a generally well-tolerated safety profile at doses that...
Immutep to Evaluate Efti in Triple Combination Therapy Phase I Study with Chemotherapy and an anti-PD-1 Therapy
New Phase I clinical trial, called INSIGHT-003, in patients with various solid tumoursExpands the evaluation of efti into a triple...
CarolinasDentist Announces Grand Opening of New Practice in Garner
Garner location becomes CarolinasDentist’s 10th office in North CarolinaGARNER, N.C., June 21, 2021 (GLOBE NEWSWIRE) -- CarolinasDentist, a local dental...
Diffusion Pharmaceuticals to Webcast Live at Life Sciences Investor Forum
Presentation Scheduled for June 24, 2021 at 11:30 a.m., EDTCHARLOTTESVILLE, Va., June 21, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc....
XOMA Declares Quarterly Preferred Stock Dividends
EMERYVILLE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board...
GSK and Vir Biotechnology Announce Continuing Progress of the COMET Clinical Development Program for Sotrovimab
– Analysis of final Day 29 data from COMET-ICE confirms sotrovimab significantly reduces hospitalization and risk of death in adults with...
Applied Therapeutics to Present on Diabetic Cardiomyopathy and Prevalence of Disease at the 81st Scientific Sessions of the 2021 Annual Meeting of the American Diabetes Association
NEW YORK, June 21, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline...
Agios Submits New Drug Application to FDA for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency
CAMBRIDGE, Mass., June 21, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular...
ROSINBOMB™ Featured in Exclusive Interview With Blunt Business on Cannabis Radio
Industry Leading Developer of Solventless Extraction Technology and Products Discuss Their Continued Commitment Empowering the Development of High-Quality Safe Extracts...